More than 300 membranes make up the SLC family of transporters, utilizing an ion gradient
or electrochemical potential difference to move their substrates across biological membranes.
The SLC16 gene family contains fourteen members. Proton-linked transportation of monocarboxylates
can be promoted by the transporters MCT1, which the SLC16A1 gene family encodes. Glycolysis
is constitutively up-regulated in cancer cells, and the amount of lactate produced as a result
is correlated with prognosis. Further speaking, SLC16A1 plays an essential role in controlling the
growth and spread of tumors, according to mounting evidence. Additionally, LncRNAs are the collective
term for all genes that produce RNA transcripts longer than 200 nucleotides but do not convert
into proteins. It has steadily developed into a hub for research, offering an innovative approach
to tumor study as technology related to molecular biology advances. The growing study has uncovered
SLC16A1-AS1, an RNA that acts as an antisense to SLC16A1, which is erroneously expressed
in various types of cancers. Therefore, we compiled the most recent information on the physiological
functions and underlying processes of SLC16A1 and the LncRNA SLC16A1-AS1 during tumor
development to explore their impact on cancer treatment and prognosis.
We compiled the most recent information on the physiological functions and underlying processes
of SLC16A1 and the LncRNA SLC16A1-AS1 during tumor development to explore their impact on
cancer treatment and prognosis.
Relevant studies were retrieved and collected through the PubMed system. After determining
SLC16A1 and SLC16A1-AS1 as the research object, we found a close relationship between
SLC16A1 and tumorigenesis as well as the influencing factors through the analysis of the research
articles.
SLC16A1 regulates lactate chemotaxis while uncovering SLC16A1- as1 as an antisense RNA acting
through multiple pathways; they affect the metabolism of tumor cells and have an impact on the
prognosis of patients with various cancers.
